376 related articles for article (PubMed ID: 31065944)
1. PGC-1α, Sirtuins and PARPs in Huntington's Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All.
Lloret A; Beal MF
Neurochem Res; 2019 Oct; 44(10):2423-2434. PubMed ID: 31065944
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase-1 inhibits mitochondrial respiration by suppressing PGC-1α activity in neurons.
Lu P; Hogan-Cann AD; Kamboj A; Roy Chowdhury SK; Aghanoori MR; Fernyhough P; Anderson CM
Neuropharmacology; 2019 Dec; 160():107755. PubMed ID: 31487495
[TBL] [Abstract][Full Text] [Related]
3. Role of PGC-1α in the Mitochondrial NAD
Koh JH; Kim JY
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925372
[TBL] [Abstract][Full Text] [Related]
4. Role of mitochondria in diabetic peripheral neuropathy: Influencing the NAD
Chandrasekaran K; Anjaneyulu M; Choi J; Kumar P; Salimian M; Ho CY; Russell JW
Int Rev Neurobiol; 2019; 145():177-209. PubMed ID: 31208524
[TBL] [Abstract][Full Text] [Related]
5. NAD
Zhao Y; Zhang J; Zheng Y; Zhang Y; Zhang XJ; Wang H; Du Y; Guan J; Wang X; Fu J
J Neuroinflammation; 2021 Sep; 18(1):207. PubMed ID: 34530866
[TBL] [Abstract][Full Text] [Related]
6. NAD+ and sirtuins in aging and disease.
Imai S; Guarente L
Trends Cell Biol; 2014 Aug; 24(8):464-71. PubMed ID: 24786309
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models.
Gong B; Pan Y; Vempati P; Zhao W; Knable L; Ho L; Wang J; Sastre M; Ono K; Sauve AA; Pasinetti GM
Neurobiol Aging; 2013 Jun; 34(6):1581-8. PubMed ID: 23312803
[TBL] [Abstract][Full Text] [Related]
8. Notoginseng Leaf Triterpenes Ameliorates OGD/R-Induced Neuronal Injury via SIRT1/2/3-Foxo3a-MnSOD/PGC-1
Xie W; Zhu T; Zhou P; Xu H; Meng X; Ding T; Nan F; Sun G; Sun X
Oxid Med Cell Longev; 2020; 2020():7308386. PubMed ID: 33149812
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway.
Wang S; Wan T; Ye M; Qiu Y; Pei L; Jiang R; Pang N; Huang Y; Liang B; Ling W; Lin X; Zhang Z; Yang L
Redox Biol; 2018 Jul; 17():89-98. PubMed ID: 29679894
[TBL] [Abstract][Full Text] [Related]
10. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes.
Yang SJ; Choi JM; Kim L; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY
J Nutr Biochem; 2014 Jan; 25(1):66-72. PubMed ID: 24314867
[TBL] [Abstract][Full Text] [Related]
12. Sirtuin deacetylases in neurodegenerative diseases of aging.
Herskovits AZ; Guarente L
Cell Res; 2013 Jun; 23(6):746-58. PubMed ID: 23689277
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha as a Novel Target for Bipolar Disorder and Other Neuropsychiatric Disorders.
Nierenberg AA; Ghaznavi SA; Sande Mathias I; Ellard KK; Janos JA; Sylvia LG
Biol Psychiatry; 2018 May; 83(9):761-769. PubMed ID: 29502862
[TBL] [Abstract][Full Text] [Related]
14. Implications of NAD
Kang BE; Choi JY; Stein S; Ryu D
Eur J Clin Invest; 2020 Oct; 50(10):e13334. PubMed ID: 32594513
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide Inhibits Glycolysis of HL-60 Cells by Modulating Sirtuin 1 (SIRT1)/Peroxisome Proliferator-Activated Receptor γ Coactivator 1α (PGC-1α)/Hypoxia-Inducible Factor-2α (HIF2α) Signaling Pathway.
Liu M; Zhou P; Li J; Jiang Y
Med Sci Monit; 2020 May; 26():e920810. PubMed ID: 32469848
[TBL] [Abstract][Full Text] [Related]
16. Implications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases.
Hikosaka K; Yaku K; Okabe K; Nakagawa T
Nutr Neurosci; 2021 May; 24(5):371-383. PubMed ID: 31280708
[TBL] [Abstract][Full Text] [Related]
17. NAD
Pollard CL; Gibb Z; Swegen A; Grupen CG
J Reprod Dev; 2022 Dec; 68(6):345-354. PubMed ID: 36171094
[TBL] [Abstract][Full Text] [Related]
18. NAD Precursors, Mitochondria Targeting Compounds and ADP-Ribosylation Inhibitors in Treatment of Inflammatory Diseases and Cancer.
Poltronieri P; Mezzolla V; Farooqi AA; Di Girolamo M
Curr Med Chem; 2021; 28(41):8453-8479. PubMed ID: 33461448
[TBL] [Abstract][Full Text] [Related]
19. NAD⁺ in aging, metabolism, and neurodegeneration.
Verdin E
Science; 2015 Dec; 350(6265):1208-13. PubMed ID: 26785480
[TBL] [Abstract][Full Text] [Related]
20. Arabidopsis sirtuins and poly(ADP-ribose) polymerases regulate gene expression in the day but do not affect circadian rhythms.
Kim JH; Bell LJ; Wang X; Wimalasekera R; Bastos HP; Kelly KA; Hannah MA; Webb AAR
Plant Cell Environ; 2021 May; 44(5):1451-1467. PubMed ID: 33464569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
